Rohto Pharmaceutical Co., Ltd., a prominent player in the health care sector, has been making significant strides in the pharmaceutical and cosmetic industries. Based in Osaka, Japan, the company has established itself as a key manufacturer and marketer of a diverse range of products. These include eyewash, bath soaps, gastrointestinal medicine, and hand cream, catering to a broad spectrum of consumer needs.
As of October 30, 2025, Rohto Pharmaceutical’s stock closed at 2,389 JPY on the Tokyo Stock Exchange, reflecting a dynamic market presence. The company’s market capitalization stands at an impressive 582.06 billion JPY, underscoring its substantial influence in the industry. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of 3,449 JPY on November 5, 2024, and a low of 1,964.5 JPY on June 5, 2025. The price-to-earnings ratio is currently 16.243, indicating a balanced valuation in the context of its earnings performance.
Rohto Pharmaceutical’s product portfolio extends beyond traditional pharmaceuticals and cosmetics. The company has ventured into the production of contact lenses and health foods, showcasing its commitment to innovation and diversification. This strategic expansion aligns with its mission to enhance consumer health and well-being through a variety of product offerings.
A notable aspect of Rohto Pharmaceutical’s business model is its licensing agreement with Mentholatum (US), a subsidiary that facilitates the sale of its brand products in the United States. This partnership has enabled Rohto to extend its market reach and strengthen its global presence.
Founded on October 1, 1961, Rohto Pharmaceutical has a rich history of over six decades in the industry. The company’s enduring legacy is built on a foundation of quality, innovation, and consumer trust. For those interested in learning more about Rohto Pharmaceutical Co., Ltd., additional information is available on their official website at www.rohto.co.jp , or through its trading activities on the Tokyo Stock Exchange.